ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
ATP13A2, a late endo-/lysosomal polyamine transporter, is implicated in a variety of neurodegenerative diseases, including Parkinson’s disease and Kufor–Rakeb syndrome, an early-onset atypical form of parkinsonism. Loss-of-function mutations in ATP13A2 result in lysosomal deficiency as a consequence...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/5/2689 |
id |
doaj-88cd71a867f44ce29722004b71c84122 |
---|---|
record_format |
Article |
spelling |
doaj-88cd71a867f44ce29722004b71c841222021-03-08T00:01:14ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01222689268910.3390/ijms22052689ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and ExternalizationJianmin Si0Chris Van den Haute1Evy Lobbestael2Shaun Martin3Sarah van Veen4Peter Vangheluwe5Veerle Baekelandt6Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Bus 802, 3000 Leuven, Flanders, BelgiumLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Bus 802, 3000 Leuven, Flanders, BelgiumLaboratory of Cellular Transport Systems, Department of Cellular and Molecular Medicine, KU Leuven, Herestraat 49, Bus 802, 3000 Leuven, Flanders, BelgiumLaboratory for Neurobiology and Gene Therapy, Department of Neurosciences, Leuven Brain Institute, KU Leuven, Herestraat 49, Bus 1023, 3000 Leuven, Flanders, BelgiumATP13A2, a late endo-/lysosomal polyamine transporter, is implicated in a variety of neurodegenerative diseases, including Parkinson’s disease and Kufor–Rakeb syndrome, an early-onset atypical form of parkinsonism. Loss-of-function mutations in ATP13A2 result in lysosomal deficiency as a consequence of impaired lysosomal export of the polyamines spermine/spermidine. Furthermore, accumulating evidence suggests the involvement of ATP13A2 in regulating the fate of α-synuclein, such as cytoplasmic accumulation and external release. However, no consensus has yet been reached on the mechanisms underlying these effects. Here, we aimed to gain more insight into how ATP13A2 is linked to α-synuclein biology in cell models with modified ATP13A2 activity. We found that loss of ATP13A2 impairs lysosomal membrane integrity and induces α-synuclein multimerization at the membrane, which is enhanced in conditions of oxidative stress or exposure to spermine. In contrast, overexpression of ATP13A2 wildtype (WT) had a protective effect on α-synuclein multimerization, which corresponded with reduced αsyn membrane association and stimulation of the ubiquitin-proteasome system. We also found that ATP13A2 promoted the secretion of α-synuclein through nanovesicles. Interestingly, the catalytically inactive ATP13A2 D508N mutant also affected polyubiquitination and externalization of α-synuclein multimers, suggesting a regulatory function independent of the ATPase and transport activity. In conclusion, our study demonstrates the impact of ATP13A2 on α-synuclein multimerization via polyamine transport dependent and independent functions.https://www.mdpi.com/1422-0067/22/5/2689ATP13A2α-synucleinα-synuclein multimerizationspermineParkinson’s disease |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jianmin Si Chris Van den Haute Evy Lobbestael Shaun Martin Sarah van Veen Peter Vangheluwe Veerle Baekelandt |
spellingShingle |
Jianmin Si Chris Van den Haute Evy Lobbestael Shaun Martin Sarah van Veen Peter Vangheluwe Veerle Baekelandt ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization International Journal of Molecular Sciences ATP13A2 α-synuclein α-synuclein multimerization spermine Parkinson’s disease |
author_facet |
Jianmin Si Chris Van den Haute Evy Lobbestael Shaun Martin Sarah van Veen Peter Vangheluwe Veerle Baekelandt |
author_sort |
Jianmin Si |
title |
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization |
title_short |
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization |
title_full |
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization |
title_fullStr |
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization |
title_full_unstemmed |
ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization |
title_sort |
atp13a2 regulates cellular α-synuclein multimerization, membrane association, and externalization |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1661-6596 1422-0067 |
publishDate |
2021-03-01 |
description |
ATP13A2, a late endo-/lysosomal polyamine transporter, is implicated in a variety of neurodegenerative diseases, including Parkinson’s disease and Kufor–Rakeb syndrome, an early-onset atypical form of parkinsonism. Loss-of-function mutations in ATP13A2 result in lysosomal deficiency as a consequence of impaired lysosomal export of the polyamines spermine/spermidine. Furthermore, accumulating evidence suggests the involvement of ATP13A2 in regulating the fate of α-synuclein, such as cytoplasmic accumulation and external release. However, no consensus has yet been reached on the mechanisms underlying these effects. Here, we aimed to gain more insight into how ATP13A2 is linked to α-synuclein biology in cell models with modified ATP13A2 activity. We found that loss of ATP13A2 impairs lysosomal membrane integrity and induces α-synuclein multimerization at the membrane, which is enhanced in conditions of oxidative stress or exposure to spermine. In contrast, overexpression of ATP13A2 wildtype (WT) had a protective effect on α-synuclein multimerization, which corresponded with reduced αsyn membrane association and stimulation of the ubiquitin-proteasome system. We also found that ATP13A2 promoted the secretion of α-synuclein through nanovesicles. Interestingly, the catalytically inactive ATP13A2 D508N mutant also affected polyubiquitination and externalization of α-synuclein multimers, suggesting a regulatory function independent of the ATPase and transport activity. In conclusion, our study demonstrates the impact of ATP13A2 on α-synuclein multimerization via polyamine transport dependent and independent functions. |
topic |
ATP13A2 α-synuclein α-synuclein multimerization spermine Parkinson’s disease |
url |
https://www.mdpi.com/1422-0067/22/5/2689 |
work_keys_str_mv |
AT jianminsi atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization AT chrisvandenhaute atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization AT evylobbestael atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization AT shaunmartin atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization AT sarahvanveen atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization AT petervangheluwe atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization AT veerlebaekelandt atp13a2regulatescellularasynucleinmultimerizationmembraneassociationandexternalization |
_version_ |
1724229209100910592 |